The state of implantable pain therapies in the United States: A nationwide survey of academic teaching programs

Gilbert J. Fanciullo, Robert J. Rose, Peter G. Lunt, Patricia K. Whalen, Edgar Ross

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The purpose of this questionnaire survey was to provide an overview of anesthesiology pain fellowship programs in the United States with regard to implantation of spinal cord stimulators (SCS) and opioid infusion devices. Of the 95 programs solicited, 80% responded to questions pertaining to the prevalence of use and technical considerations of implantation. Of the responding programs, 87% report implanting SCS, and 84% report implanting neuraxial infusion pumps. All programs perform a stimulation or infusion trial before implantation, although the duration varied from a trial in the operating room at the time of implantation to 25 days. Of the programs, 83% implant cylindrical leads, and 17% implant flat leads via laminectomy for their nonrevision SCS implants. Morphine, bupivacaine, hydromorphone, and baclofen are the most commonly used drugs and are used in implanted pumps by >50% of respondents. The question of industry-sponsored pain fellow education in implantable techniques is addressed. Implications: Of the pain teaching programs in the United States, 80% responded to a questionnaire eliciting information about the implantation of spinal cord-stimulating and opioid infusion devices. The range and diversity of responses imply a lack of agreement about implantation techniques, drugs, and protocols.

Original languageEnglish (US)
Pages (from-to)1311-1316
Number of pages6
JournalAnesthesia and Analgesia
Volume88
Issue number6
DOIs
StatePublished - 1999

Fingerprint

Spinal Cord
Teaching
Pain
Opioid Analgesics
Hydromorphone
Infusion Pumps
Equipment and Supplies
Baclofen
Laminectomy
Anesthesiology
Bupivacaine
Operating Rooms
Therapeutics
Pharmaceutical Preparations
Morphine
Industry
Education
Surveys and Questionnaires

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The state of implantable pain therapies in the United States : A nationwide survey of academic teaching programs. / Fanciullo, Gilbert J.; Rose, Robert J.; Lunt, Peter G.; Whalen, Patricia K.; Ross, Edgar.

In: Anesthesia and Analgesia, Vol. 88, No. 6, 1999, p. 1311-1316.

Research output: Contribution to journalArticle

Fanciullo, Gilbert J. ; Rose, Robert J. ; Lunt, Peter G. ; Whalen, Patricia K. ; Ross, Edgar. / The state of implantable pain therapies in the United States : A nationwide survey of academic teaching programs. In: Anesthesia and Analgesia. 1999 ; Vol. 88, No. 6. pp. 1311-1316.
@article{68599fdde694438a9044e790c6e366df,
title = "The state of implantable pain therapies in the United States: A nationwide survey of academic teaching programs",
abstract = "The purpose of this questionnaire survey was to provide an overview of anesthesiology pain fellowship programs in the United States with regard to implantation of spinal cord stimulators (SCS) and opioid infusion devices. Of the 95 programs solicited, 80{\%} responded to questions pertaining to the prevalence of use and technical considerations of implantation. Of the responding programs, 87{\%} report implanting SCS, and 84{\%} report implanting neuraxial infusion pumps. All programs perform a stimulation or infusion trial before implantation, although the duration varied from a trial in the operating room at the time of implantation to 25 days. Of the programs, 83{\%} implant cylindrical leads, and 17{\%} implant flat leads via laminectomy for their nonrevision SCS implants. Morphine, bupivacaine, hydromorphone, and baclofen are the most commonly used drugs and are used in implanted pumps by >50{\%} of respondents. The question of industry-sponsored pain fellow education in implantable techniques is addressed. Implications: Of the pain teaching programs in the United States, 80{\%} responded to a questionnaire eliciting information about the implantation of spinal cord-stimulating and opioid infusion devices. The range and diversity of responses imply a lack of agreement about implantation techniques, drugs, and protocols.",
author = "Fanciullo, {Gilbert J.} and Rose, {Robert J.} and Lunt, {Peter G.} and Whalen, {Patricia K.} and Edgar Ross",
year = "1999",
doi = "10.1097/00000539-199906000-00021",
language = "English (US)",
volume = "88",
pages = "1311--1316",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The state of implantable pain therapies in the United States

T2 - A nationwide survey of academic teaching programs

AU - Fanciullo, Gilbert J.

AU - Rose, Robert J.

AU - Lunt, Peter G.

AU - Whalen, Patricia K.

AU - Ross, Edgar

PY - 1999

Y1 - 1999

N2 - The purpose of this questionnaire survey was to provide an overview of anesthesiology pain fellowship programs in the United States with regard to implantation of spinal cord stimulators (SCS) and opioid infusion devices. Of the 95 programs solicited, 80% responded to questions pertaining to the prevalence of use and technical considerations of implantation. Of the responding programs, 87% report implanting SCS, and 84% report implanting neuraxial infusion pumps. All programs perform a stimulation or infusion trial before implantation, although the duration varied from a trial in the operating room at the time of implantation to 25 days. Of the programs, 83% implant cylindrical leads, and 17% implant flat leads via laminectomy for their nonrevision SCS implants. Morphine, bupivacaine, hydromorphone, and baclofen are the most commonly used drugs and are used in implanted pumps by >50% of respondents. The question of industry-sponsored pain fellow education in implantable techniques is addressed. Implications: Of the pain teaching programs in the United States, 80% responded to a questionnaire eliciting information about the implantation of spinal cord-stimulating and opioid infusion devices. The range and diversity of responses imply a lack of agreement about implantation techniques, drugs, and protocols.

AB - The purpose of this questionnaire survey was to provide an overview of anesthesiology pain fellowship programs in the United States with regard to implantation of spinal cord stimulators (SCS) and opioid infusion devices. Of the 95 programs solicited, 80% responded to questions pertaining to the prevalence of use and technical considerations of implantation. Of the responding programs, 87% report implanting SCS, and 84% report implanting neuraxial infusion pumps. All programs perform a stimulation or infusion trial before implantation, although the duration varied from a trial in the operating room at the time of implantation to 25 days. Of the programs, 83% implant cylindrical leads, and 17% implant flat leads via laminectomy for their nonrevision SCS implants. Morphine, bupivacaine, hydromorphone, and baclofen are the most commonly used drugs and are used in implanted pumps by >50% of respondents. The question of industry-sponsored pain fellow education in implantable techniques is addressed. Implications: Of the pain teaching programs in the United States, 80% responded to a questionnaire eliciting information about the implantation of spinal cord-stimulating and opioid infusion devices. The range and diversity of responses imply a lack of agreement about implantation techniques, drugs, and protocols.

UR - http://www.scopus.com/inward/record.url?scp=0032990994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032990994&partnerID=8YFLogxK

U2 - 10.1097/00000539-199906000-00021

DO - 10.1097/00000539-199906000-00021

M3 - Article

C2 - 10357336

AN - SCOPUS:0032990994

VL - 88

SP - 1311

EP - 1316

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 6

ER -